SENORES PHARMACEUTICALS L (SENORES) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.029x

Based on the latest financial reports, SENORES PHARMACEUTICALS L (SENORES) has a cash flow conversion efficiency ratio of 0.029x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs242.20 Million ≈ $2.62 Million USD) by net assets (Rs8.34 Billion ≈ $90.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see SENORES stock market capitalisation for the company's overall valuation and market capitalisation.

SENORES PHARMACEUTICALS L - Cash Flow Conversion Efficiency Trend (2022–2026)

This chart illustrates how SENORES PHARMACEUTICALS L's cash flow conversion efficiency has evolved over time, based on yearly financial data.

SENORES PHARMACEUTICALS L Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SENORES PHARMACEUTICALS L ranked by their cash flow conversion efficiency. Explore SENORES cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
EverQuote Inc Class A NASDAQ:EVER	0.123x
Dongguan Golden Sun Abrasives Co Ltd SHE:300606	0.038x
Unionman Technology Co. Ltd. A SHG:688609	0.316x
MNTN, Inc. NYSE:MNTN	0.081x
Ningbo Zhongbai Co Ltd SHG:600857	0.015x
Tanla Platforms Limited NSE:TANLA	0.074x
Dakota Gold Corp. NYSE MKT:DC	-0.063x
Bank of Kaohsiung Ltd TW:2836	-0.099x

Annual Cash Flow Conversion Efficiency for SENORES PHARMACEUTICALS L (2022–2026)

The table below shows the annual cash flow conversion efficiency of SENORES PHARMACEUTICALS L from 2022 to 2026. View SENORES live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs9.65 Billion ≈ $104.31 Million	Rs620.50 Million ≈ $6.71 Million	0.064x	+101.33%
2025-03-31	Rs94.96 Million ≈ $1.03 Million	Rs-459.20 Million ≈ $-4.97 Million	-4.836x	-4260.01%
2024-03-31	Rs2.32 Billion ≈ $25.06 Million	Rs-257.00 Million ≈ $-2.78 Million	-0.111x	-367.70%
2023-03-31	Rs454.99 Million ≈ $4.92 Million	Rs-10.79 Million ≈ $-116.69K	-0.024x	+91.69%
2022-03-31	Rs365.90 Million ≈ $3.96 Million	Rs-104.47 Million ≈ $-1.13 Million	-0.286x	--

About SENORES PHARMACEUTICALS L

NSE:SENORES India Drug Manufacturers - General

Market Cap

$698.57 Million

Rs64.59 Billion INR

Market Cap Rank

#10670 Global

#533 in India

Share Price

Rs1402.60

Change (1 day)

+0.00%

52-Week Range

Rs673.60 - Rs1550.90

All Time High

Rs1550.90